Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University: Ovarian Neoplasms trials
The registry lists 20 Ovarian Neoplasms studies with Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University as lead sponsor. 8 are open to participants now and 0 have results posted.
Phase 1 1Phase 2 6No phase 13(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- The Efficacy and Safety of Paclitaxel Monotherapy Versus Paclitaxel-Carboplatin Combination as Neoadjuvant Chemotherapy in Advanced Ovarian Cancer With High PARK2 ExpressionNot yet recruitingNCT07401654Phase 2
- Liposomal Irinotecan Combined With Sintilimab and Anlotinib in the Treatment of Recurrent or Persistent Ovarian Clear Cell CarcinomaNot yet recruitingNCT07239622Phase 2
- Efficacy and Safety of Sacituzumab in Patients With OCCC After Immunotherapy ProgressionNot yet recruitingNCT07168083
- Exploratory Study on the Correlation Between HRD Score and PARPi Efficacy Based on Chinese Ovarian Cancer PatientsRecruitingNCT06622798
- RC48 in Combination With AK104 and Bevacizumab in OCCCRecruitingNCT06540729Phase 2
- Satisfactory Debulking Prediction Model for Advanced Ovarian Cancer Based on PET-CT Image DataRecruitingNCT06533709
- Administration of Hyperthermic Intraperitoneal Chemotherapy in the General WardNot yet recruitingNCT06277947Not applicable
- A Study to Analyze Data on Metastatic Ovarian Cancer Using Multi-omicsRecruitingNCT05251883
- Development and Validation of a Prediction Model for AKI Following Cisplatin-Based HIPEC in Patients With Ovarian CancerCompletedNCT06697613
- New Prognostic Index for Neoadjuvant Chemotherapy Outcome in Patients With Advanced High-grade Serous Ovarian CancerStatus unknownNCT06120309
- Effect of Sodium Thiosulfate on Nephrotoxicity of Cisplatin Intraperitoneal Heat-perfusion ChemotherapyStatus unknownNCT05877911Phase 2
- Early Detection of Ovarian Cancer Using Plasma Cell-free DNA Fragmentomics (Prospective Study)Status unknownNCT05693987
- Early Detection of Ovarian Cancer Using Plasma Cell-free DNA Fragmentomics (Retrospective Study)Status unknownNCT05693974
- A Phase I Dose-finding Trial of Hyperthermic Intraperitoneal Paclitaxel Combined With CisplatinStatus unknownNCT05620654Phase 1
- First-line Olaparib Combined With Bevacizumab Maintenance TherapyStatus unknownNCT05440578
- The Efficacy of Hyperthermic Intraperitoneal Chemotherapy to Ovarian Cancer Patients With Homologous Recombination Repair Defect and Residual: a Prospective Cohort StudyStatus unknownNCT05265117
- Efficacy of Neoadjuvant Hyperthermic Intraperitoneal Chemotherapy in Advanced High-grade Serous Ovarian Cancer (the NHIPEC Trial)Status unknownNCT05246020Phase 2
- Study on the Consistency Evaluation of Organoids Used in the Clinical Treatment of Ovarian Cancer With Anti-tumor DrugsStatus unknownNCT05175326
- Outcomes of First-line Olaparib Mono-maintenance therapy-a Multicenter, Retrospective Study Using Data From Real-world Clinical SettingStatus unknownNCT05153603
- Anlotinib Combined With Niraparib Dual Therapy in Platinum-resistant Recurrent Ovarian Clear Cell Carcinoma.CompletedNCT05130515Phase 2